KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Enterprise Value (2017 - 2026)

Guardant Health's Enterprise Value history spans 9 years, with the latest figure at -$1.2 billion for Q4 2025.

  • On a quarterly basis, Enterprise Value fell 43.05% to -$1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.2 billion, a 43.05% decrease, with the full-year FY2025 number at -$1.2 billion, down 43.05% from a year prior.
  • Enterprise Value hit -$1.2 billion in Q4 2025 for Guardant Health, down from -$580.0 million in the prior quarter.
  • Over the last five years, Enterprise Value for GH hit a ceiling of -$580.0 million in Q3 2025 and a floor of -$1.9 billion in Q1 2021.
  • Historically, Enterprise Value has averaged -$1.1 billion across 5 years, with a median of -$960.2 million in 2022.
  • Biggest five-year swings in Enterprise Value: crashed 296.35% in 2021 and later soared 50.72% in 2022.
  • Tracing GH's Enterprise Value over 5 years: stood at -$932.7 million in 2021, then decreased by 8.41% to -$1.0 billion in 2022, then decreased by 15.57% to -$1.2 billion in 2023, then rose by 28.12% to -$840.0 million in 2024, then crashed by 43.05% to -$1.2 billion in 2025.
  • Business Quant data shows Enterprise Value for GH at -$1.2 billion in Q4 2025, -$580.0 million in Q3 2025, and -$629.1 million in Q2 2025.